Jan-Olav Henck, PhD,
chief scientific officer
Jan-Olav Henck, PhD, chief scientific officer at Aptuit, discusses strategies and considerations in polymorph screening with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).
Today’s analytical laboratory equipment reflects the realities of downsizing, outsourcing, and the need for speed.
The agency recommends the approval of Zavicefta to treat infections caused by resistant bacteria.
The agency extends the indication of the drug in combination with bendamustine.
The agency found no differences in risk of pneumonia for different products.
Ingredients Insider Cynthia ChallenerConjugation Chemistry with Highly Potent Compounds